These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22105595)

  • 21. Accuracy of drawing coagulation samples from heparinized arterial lines.
    Templin K; Shively M; Riley J
    Am J Crit Care; 1993 Jan; 2(1):88-95. PubMed ID: 8353585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the Single-Syringe Push-Pull Technique With the Discard Technique for Obtaining Blood Samples From Pediatric Central Venous Access Devices.
    Hess S; Decker M
    J Pediatr Oncol Nurs; 2017; 34(6):381-386. PubMed ID: 28681653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN).
    Zara GP; Cavalli R; Fundarò A; Bargoni A; Caputo O; Gasco MR
    Pharmacol Res; 1999 Sep; 40(3):281-6. PubMed ID: 10479474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicokinetics of the active doxorubicin metabolite, doxorubicinol, in sulphur-crested cockatoos (Cacatua galerita).
    Gilbert CM; Filippich LJ; McGeary RP; Charles BG
    Res Vet Sci; 2007 Aug; 83(1):123-9. PubMed ID: 17197005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of factors affecting in vitro doxorubicin release from PEGylated liposomal doxorubicin for the development of in vitro release testing conditions.
    Shibata H; Izutsu K; Yomota C; Okuda H; Goda Y
    Drug Dev Ind Pharm; 2015; 41(8):1376-86. PubMed ID: 25170659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantification of doxorubicin in plasma--a comparative study of capillary and venous blood sampling.
    Palm C; Björk O; Björkholm M; Eksborg S
    Anticancer Drugs; 2001 Nov; 12(10):859-64. PubMed ID: 11707655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reliability of an intravenous intermittent access port (saline lock) for obtaining blood samples for coagulation studies.
    Arrants J; Willis ME; Stevens B; Gripkey L; Herman JA; Hernandez-Brooks L; Eaker JE
    Am J Crit Care; 1999 Sep; 8(5):344-8. PubMed ID: 10467472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing the Push-Pull Versus Discard Blood Sample Method From Adult Central Vascular Access Devices.
    Byrne D
    J Infus Nurs; 2016; 39(3):130-5. PubMed ID: 27074989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of free and liposome-associated doxorubicin and vincristine levels in plasma under equilibrium conditions employing ultrafiltration techniques.
    Mayer LD; St-Onge G
    Anal Biochem; 1995 Dec; 232(2):149-57. PubMed ID: 8747469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obtaining reliable plasma sodium and glucose determinations from pulmonary artery catheters.
    Carlson KK; Snyder ML; LeClair HW; Underhill SL; Ashwood ER; Detter JC
    Heart Lung; 1990 Nov; 19(6):613-9. PubMed ID: 2228651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of DOX bioavailability in biological samples of mice by sensitive and precise HPLC assay.
    Zhang C; Wu Y; Dong Y; Xu H; Zhao L
    Pharm Biol; 2016; 54(1):55-61. PubMed ID: 25880143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reducing the risk of fatal and disabling hypoglycaemia: a comparison of arterial blood sampling systems.
    Brennan KA; Eapen G; Turnbull D
    Br J Anaesth; 2010 Apr; 104(4):446-51. PubMed ID: 20190258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantifying the minimum discard sample required for accurate arterial blood gases.
    Preusser BA; Lash J; Stone KS; Winningham ML; Gonyon D; Nickel JT
    Nurs Res; 1989; 38(5):276-9. PubMed ID: 2798152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of the anticancer drugs doxorubicin, mitoxantrone and topotecan in tumors and normal tissues.
    Patel KJ; Trédan O; Tannock IF
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):127-38. PubMed ID: 23680920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution of pirarubicin in human blood.
    Nagasawa K; Kitada N; Tsuji C; Ogawa M; Yokoyama T; Ohnishi N; Iwakawa S; Okumura K
    Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2866-9. PubMed ID: 1464120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reinfusion of discard blood from venous access devices.
    Cosca PA; Smith S; Chatfield S; Meleason A; Muir CA; Nerantzis S; Petrofsky M; Williams S
    Oncol Nurs Forum; 1998 Jul; 25(6):1073-6. PubMed ID: 9679265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of pirarubicin in plasma and cerebrospinal fluid.
    Morikawa N; Takeyama M; Mori T; Hori S
    Ann Pharmacother; 1998 Feb; 32(2):269. PubMed ID: 9496418
    [No Abstract]   [Full Text] [Related]  

  • 38. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
    Cui J; Li C; Guo W; Li Y; Wang C; Zhang L; Zhang L; Hao Y; Wang Y
    J Control Release; 2007 Apr; 118(2):204-15. PubMed ID: 17239468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing two methods to obtain blood specimens from pediatric central venous catheters.
    Barton SJ; Chase T; Latham B; Rayens MK
    J Pediatr Oncol Nurs; 2004; 21(6):320-6. PubMed ID: 15475468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A general method to determine sampling windows for nonlinear mixed effects models with an application to population pharmacokinetic studies.
    Foo LK; McGree J; Duffull S
    Pharm Stat; 2012; 11(4):325-33. PubMed ID: 22411749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.